Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Drug Safety Update - October 2017

The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for October 2017 (PDF).

This issue warns clinicians that Solu-Medrone 40mg contains lactose derived from cows' milk and as such it may contain trace amounts of milk proteins. As such, this product must not be used in patients with known or suspected allergy to cows' milk. Serious allergic reactions have been reported.

It is also noted that gabapentin has been associated with a rare risk of severe respiratory depression even without concomitant opioid medicines. Patients at higher risk of experiencing severe respiratory depression include those with compromised respiratory function, respiratory or neurological disease, renal impairment, concomitant use of CNS depressants and elderly people. Dose adjustments might be necessary in these patients. Gabapentin is usually started at low dose and increased based on efficacy and tolerance; directly asking patients about respiratory symptoms during dose increases may be prudent.

Isotretinoin has been associated with rare reports of erectile dysfunction and decreased libido. Further reporting of any suspected adverse events is recommended.

Clinicians are also reminded of the potentially fatal risk of intestinal obstruction, faecal impaction, and paralytic ileus with Clozapine. It is therefore vital that constipation is recognised and actively treated and particular care should be exercised in patients receiving other drugs known to cause constipation, those with history of colonic disease or lower abdominal surgery, and in patients aged 60 years and older.

Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.

Share 'Drug Safety Update - October 2017' on Email Share 'Drug Safety Update - October 2017' on Delicious Share 'Drug Safety Update - October 2017' on Digg Share 'Drug Safety Update - October 2017' on Facebook Share 'Drug Safety Update - October 2017' on Google+ Share 'Drug Safety Update - October 2017' on reddit Share 'Drug Safety Update - October 2017' on StumbleUpon Share 'Drug Safety Update - October 2017' on Twitter

atomic-wealth

One Comments to “Drug Safety Update - October 2017”

  1. […] Lastly, the summary of letters sent to healthcare professionals in October includes a letter regarding Solu-Medrone 40 mg containing lactose derived from cows' milk and potentially milk proteins as reported in the update last month. […]

    Pingback by Drug Safety Update - November 2017 - Prescribing Advice For GPs — November 27, 2017 #
    Reply

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,658 spam comments.

atomic-wealth
fond-illness
summer